Advancing Access to High Quality, Affordable Diabetes Care Through Private Health Insurance Regulation

Diabetes affects millions, yet barriers to affordable care and comprehensive coverage continue to undermine health outcomes and financial stability. Among those affected are people with insulin-requiring diabetes (IRD) who depend on access to essential services, including medications, supplies, and devices. With support from The Leona M. and Harry B. Helmsley Charitable Trust, CHIR researchers are analyzing how private health insurance coverage and the regulation thereof affect patients with IRD. Their findings aim to raise awareness and drive engagement on pressing private health insurance issues in this space.

To view and download our report and additional resources, please click below. To have future diabetes-related resources and events delivered straight to your inbox, sign up here.